Skip to content

CapEx at other companies

LifeStance Health Group logo
LifeStance Health GroupLFST
$10.77M+50.2%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$32K+52.4%
Stereotaxis logo
StereotaxisSTXS
$79K
Neuropace, Inc. logo
Neuropace, Inc.NPCE
$117K+216%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$9.1M-15.0%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$645K+252%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's capex?
Neuronetics (STIM) reported capex of $197K in Q1 2026.
How has Neuronetics's capex changed year-over-year?
Neuronetics's capex decreased by 10.0% year-over-year, from $219K to $197K.
What is the long-term trend for Neuronetics's capex?
Over 4 years (2021 to 2025), Neuronetics's capex has grown at a -23.6% compound annual growth rate (CAGR), from $2.35M to $801K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.